Pulsed field ablation versus cryoballoon ablation for persistent atrial fibrillation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with persistent atrial fibrillation who are eligible for catheter ablation will undergo ablation using either pulsed field ablation or cryoballoon ablation and will be followed for rhythm outcomes and safety. The trial enrolls patients aged 18–85 whose persistent AF has lasted less than one year or required cardioversion, following current Japanese guidelines. Key measurements include recurrence of atrial fibrillation, procedure-related complications, and symptom improvement over scheduled follow-up visits. The study is conducted at Kitasato University School of Medicine with collaborating regional hospitals in Kanagawa, Japan.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age between 18 and 85 years
* Diagnosed with PeAF (lasting less than one year or requiring cardioversion)
* Eligible for catheter ablation according to current Japanese guidelines
* Provided written informed consent

Exclusion Criteria:

* Paroxysmal or long-standing persistent AF (duration \>1 year)

Where it's running

• Kitasato University School of Medicine
  Sagamihara, Kanagawa, Japan Recruiting

Study contacts

• Study coordinator: Hidehira Fukaya, MD, PhD
• Email: hidehira@med.kitasato-u.ac.jp
• Phone: +81-778-8111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• FARAFLEX Mapping and Pulsed Field Ablation for Atrial Fibrillation

  This trial tests the FARAFLEX Mapping and PFA System to see if it can safely help adults with drug-refractory paroxysmal or persistent atrial fibrillation.

  Recruiting at 13 sites Boston Scientific Corporation · Jonesboro, Arkansas and 12 other locations · NCT07575269

• Pulsed field ablation for atrial fibrillation in underrepresented minority patients

  This registry will test how well Boston Scientific pulsed field ablation works and how safe it is for Black, Hispanic, Asian, and other underrepresented adults with paroxysmal or persistent atrial fibrillation.

  Recruiting at 2 sites Icahn School of Medicine at Mount Sinai · New York, New York and 1 other locations · NCT07535268

• Left Atrial Appendage Occlusion and Rhythm Restoration in AF Patients

  This trial tests a combined procedure using the Volt PFA System and Amulet 2 to see if it safely and feasibly treats atrial fibrillation while also closing the left atrial appendage in adults with AF.

  Recruiting at 13 sites Abbott Medical Devices · Brussels, B CAP R and 15 other locations · NCT07523620

• Qidong Yixin Granules to prevent atrial fibrillation returning after ablation

  This trial tests whether taking Qidong Yixin Granules after catheter ablation can lower the chance of atrial fibrillation coming back within a year in adults with persistent AF.

  Recruiting Phase 4 Sir Run Run Shaw Hospital · Hangzhou and 4 other locations · NCT07508618

• FARAPULSE pulsed-field waveform treatment for paroxysmal and persistent atrial fibrillation

  This will test new pulsed electrical waveforms delivered by the FARAPULSE PFA system to treat adults with paroxysmal or persistent atrial fibrillation.

  Recruiting at 3 sites Boston Scientific Corporation · Split and 3 other locations · NCT07444320

• PVI Alone vs PVI Plus PWI and SVCI with PFA in Persistent AF

  This study tests whether adding posterior wall isolation and superior vena cava isolation to pulmonary vein isolation with pulsed-field ablation helps people with persistent atrial fibrillation stay in rhythm.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07405359

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.